Terence C. Burns
Mayo Clinic · Mayo Clinic in Rochester
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Terence C. Burns as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:02 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07468136 · Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasMayo Clinic · recruiting · Anaplastic Oligodendroglioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4 · principal investigator
- Early Ph1NCT07076472 · Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent GlioblastomaMayo Clinic · recruiting · Progressive Glioblastoma, Recurrent Glioblastoma · principal investigator
- Early Ph1NCT07025226 · Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual DiseaseMayo Clinic · recruiting · Glioma · principal investigator
- N/ANCT05733312 · Extracellular Impact of Ultrasound-induced Blood-brain Barrier DisruptionMayo Clinic · recruiting · Brain Tumor · principal investigator
- Ph1NCT05720624 · Pharmacodynamic Analyses of Metabolic Agents Following Brain RadiationMayo Clinic · withdrawn · Malignant Central Nervous System Neoplasm · principal investigator
- Early Ph1NCT05717153 · Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade GliomaMayo Clinic · recruiting · Diffuse Glioma, Malignant Glioma · principal investigator
- N/ANCT04047264 · Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System LesionsMayo Clinic · recruiting · Glioma, Glioblastoma, Metastatic Malignant Neoplasm in the Brain
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiformeR44CA275508 · NCI · SONALASENSE INC · PI Stuart Marcus · fiscal years 2023 to 2026Named on NCT07076472
- Glioma intelligence from behind enemy linesR37CA276851 · NCI · MAYO CLINIC ROCHESTER · PI Terry Burns · fiscal years 2023 to 2026Named on NCT05717153, NCT04047264
- Intracranial D-2-Hydroxyglutarate as a Monitoring Biomarker for IDH-mutant Glioma.R61NS122096 · NINDS · MAYO CLINIC ROCHESTER · PI Terry Burns · fiscal years 2022 to 2024Named on NCT04047264
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:02 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed